The American Strategic Investment Company is in contract to sell 9 Times Square for $63.5 million to an unknown buyer, the investor announced in a press release. ASIC purchased 9 Times Square in ...
Nine Square Therapeutics Inc. has disclosed mucolipin-1 modulators reported to be useful for the treatment of metabolic disease, neurodegeneration, aging, immunological disorders, inflammatory ...